Praxis Precision Medicines
PRAX
PRAX
86 hedge funds and large institutions have $43.1M invested in Praxis Precision Medicines in 2023 Q1 according to their latest regulatory filings, with 12 funds opening new positions, 39 increasing their positions, 19 reducing their positions, and 29 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding in top 10
Funds holding in top 10: →
more ownership
Funds ownership: →
less funds holding
Funds holding: →
59% less first-time investments, than exits
New positions opened: 12 | Existing positions closed: 29
60% less capital invested
Capital invested by funds: $108M → $43.1M (-$64.7M)
92% less call options, than puts
Call options by funds: $17K | Put options by funds: $204K
Holders
86
Holding in Top 10
3
Calls
$17K
Puts
$204K
Top Buyers
| 1 | +$4.19M | |
| 2 | +$3.46M | |
| 3 | +$2.03M | |
| 4 |
TLP
Tri Locum Partners
New York
|
+$1.99M |
| 5 |
GPP
Great Point Partners
Greenwich,
Connecticut
|
+$1.64M |
Top Sellers
| 1 | -$8.37M | |
| 2 | -$3.77M | |
| 3 | -$3.11M | |
| 4 |
AG
Artal Group
Luxembourg
|
-$2.86M |
| 5 |
OCA
Octagon Capital Advisors
New York
|
-$1.9M |